March 24, 2024 9:02 PM
Bharat Biotech starts clinical trials of Tuberculosis vaccine MTBVAC in India
Bharat Biotech International Ltd said it started clinical trials of the Tuberculosis vaccine MTBVAC on adults in India. This is the first vaccine against Tuberculosis derived from a human source by the Spanish bio-pharmaceutical company, Biofabri. The trials are carried out by Bharat Biotech in clo...